Chun Shik Park
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Chun Shik Park has a total of 167 co-authors. Here are the top co-authors by number of shared publications:
- Charles G. Mullighan
St Jude Children's Research Hospital, Memphis, Tennessee, United States
86 shared publications - Ilaria Iacobucci
St. Jude Children's Research Hospital, Memphis, Tennessee, United States
85 shared publications - Qingsong Gao
St. Jude Children's Research Hospital, Memphis, Tennessee, United States
85 shared publications - David Trent Teachey
Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
74 shared publications - Lindsey E. Montefiori
St. Jude Children's Research Hospital, Memphis, Tennessee, United States
74 shared publications - Petri Pölönen
St Jude Children's Research Hospital, Memphis, Tennessee, United States
74 shared publications
Latest Publications
- 15 October 2026
- Published by American Society of Hematology in Blood
- Vol. 148 (16) , 1952-1954
Untangling the ties that bind: the NG2-ITGA4 axis in B-ALL
- 15 October 2026
- Published by American Society of Hematology in Blood
- Vol. 148 (16) , 1952-1954
Untangling the ties that bind: the NG2-ITGA4 axis in B-ALL
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S1 from Biologic and Clinical Analysis of Childhood Gamma Delta T-ALL Identifies LMO2/STAG2 Rearrangements as Extremely High Risk
A multi-national consortium of γδ T-ALL study.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S1 from Biologic and Clinical Analysis of Childhood Gamma Delta T-ALL Identifies LMO2/STAG2 Rearrangements as Extremely High Risk
A multi-national consortium of γδ T-ALL study.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S16 from Biologic and Clinical Analysis of Childhood Gamma Delta T-ALL Identifies LMO2/STAG2 Rearrangements as Extremely High Risk
Differentially expressed genes (adjusted P <0.01 ) between PF382-STAG2KO and PF382-WT.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S16 from Biologic and Clinical Analysis of Childhood Gamma Delta T-ALL Identifies LMO2/STAG2 Rearrangements as Extremely High Risk
Differentially expressed genes (adjusted P <0.01 ) between PF382-STAG2KO and PF382-WT.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S2 from Biologic and Clinical Analysis of Childhood Gamma Delta T-ALL Identifies LMO2/STAG2 Rearrangements as Extremely High Risk
Comparison of clinical characteristics and outcomes between gamma delta T-ALL and non-gamma delta T-ALL.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S2 from Biologic and Clinical Analysis of Childhood Gamma Delta T-ALL Identifies LMO2/STAG2 Rearrangements as Extremely High Risk
Comparison of clinical characteristics and outcomes between gamma delta T-ALL and non-gamma delta T-ALL.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S4 from Biologic and Clinical Analysis of Childhood Gamma Delta T-ALL Identifies LMO2/STAG2 Rearrangements as Extremely High Risk
The genomic features of “Chromosome gains” and “TLX3” subtypes.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S4 from Biologic and Clinical Analysis of Childhood Gamma Delta T-ALL Identifies LMO2/STAG2 Rearrangements as Extremely High Risk
The genomic features of “Chromosome gains” and “TLX3” subtypes.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S2 from Biologic and Clinical Analysis of Childhood Gamma Delta T-ALL Identifies LMO2/STAG2 Rearrangements as Extremely High Risk
The gene expression profiles of γδ T-ALL.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S2 from Biologic and Clinical Analysis of Childhood Gamma Delta T-ALL Identifies LMO2/STAG2 Rearrangements as Extremely High Risk
The gene expression profiles of γδ T-ALL.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S21 from Biologic and Clinical Analysis of Childhood Gamma Delta T-ALL Identifies LMO2/STAG2 Rearrangements as Extremely High Risk
Compounds used in single-dose (10uM) drug screening.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S21 from Biologic and Clinical Analysis of Childhood Gamma Delta T-ALL Identifies LMO2/STAG2 Rearrangements as Extremely High Risk
Compounds used in single-dose (10uM) drug screening.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S12 from Biologic and Clinical Analysis of Childhood Gamma Delta T-ALL Identifies LMO2/STAG2 Rearrangements as Extremely High Risk
Differentially expressed genes (adjusted P <0.01 ) in STAG2/LMO2 subtype compared to other T-ALL cases.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S12 from Biologic and Clinical Analysis of Childhood Gamma Delta T-ALL Identifies LMO2/STAG2 Rearrangements as Extremely High Risk
Differentially expressed genes (adjusted P <0.01 ) in STAG2/LMO2 subtype compared to other T-ALL cases.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S19 from Biologic and Clinical Analysis of Childhood Gamma Delta T-ALL Identifies LMO2/STAG2 Rearrangements as Extremely High Risk
Differential peaks of H3K27ac and differentially expressed genes in gene-edited PF382 model.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S19 from Biologic and Clinical Analysis of Childhood Gamma Delta T-ALL Identifies LMO2/STAG2 Rearrangements as Extremely High Risk
Differential peaks of H3K27ac and differentially expressed genes in gene-edited PF382 model.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S7 from Biologic and Clinical Analysis of Childhood Gamma Delta T-ALL Identifies LMO2/STAG2 Rearrangements as Extremely High Risk
Detected structural variants by whole genome sequencing.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S7 from Biologic and Clinical Analysis of Childhood Gamma Delta T-ALL Identifies LMO2/STAG2 Rearrangements as Extremely High Risk
Detected structural variants by whole genome sequencing.